Unique insertion/deletion polymorphisms within histidine-rich region of histidine-rich glycoprotein in Thoroughbred horses.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 01 2023
06 01 2023
Historique:
received:
17
08
2022
accepted:
02
01
2023
entrez:
7
1
2023
pubmed:
8
1
2023
medline:
11
1
2023
Statut:
epublish
Résumé
Histidine-rich glycoprotein (HRG) is abundant plasma protein with various effects on angiogenesis, coagulation, and immune responses. Previously, we identified the base and amino acid sequences of equine HRG (eHRG) and revealed that eHRG regulates neutrophil functions. In this study, we first conducted a large-scale gene analysis with DNA samples extracted from 1700 Thoroughbred horses and identified unique insertion/deletion polymorphisms in the histidine-rich region (HRR) of eHRG. Here we report two types of polymorphisms (deletion type 1 [D1] and deletion type 2 [D2]) containing either a 45 bp or 90 bp deletion in the HRR of eHRG, and five genotypes of eHRG (insertion/insertion [II], ID1, ID2, D1D1, and D1D2) in Thoroughbred horses. Allele frequency of I, D1, and D2, was 0.483, 0.480, and 0.037 and the incidence of each genotype was II: 23.4%, ID1: 46.2%, ID2: 3.6%, D1D1: 23.1%, and D1D2: 3.7%, respectively. The molecular weights of each plasma eHRG protein collected from horses with each genotype was detected as bands of different molecular size, which corresponded to the estimated amino acid sequence. The nickel-binding affinity of the D1 or D2 deletion eHRG was reduced, indicating a loss of function at the site. eHRG proteins show a variety of biological and immunological activities in vivo, and HRR is its active center, suggesting that genetic polymorphisms in eHRG may be involved in the performance in athletic ability, productivity, and susceptibility to infectious diseases in Thoroughbred horses.
Identifiants
pubmed: 36609619
doi: 10.1038/s41598-023-27374-0
pii: 10.1038/s41598-023-27374-0
pmc: PMC9822902
doi:
Substances chimiques
histidine-rich proteins
0
Histidine
4QD397987E
Blood Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
300Informations de copyright
© 2023. The Author(s).
Références
Arch Dermatol Res. 2007 Feb;298(9):413-20
pubmed: 17091276
J Thromb Haemost. 2015 Jan;13(1):101-10
pubmed: 25353308
J Equine Vet Sci. 2021 Jul;102:103620
pubmed: 34119191
Thromb Haemost. 2001 May;85(5):890-5
pubmed: 11372684
Vet Rec. 2011 Nov 19;169(21):543
pubmed: 22102349
Am J Hum Genet. 2010 Apr 9;86(4):626-31
pubmed: 20303064
FEBS Lett. 2017 Jan;591(1):164-176
pubmed: 27930811
Crit Care. 2018 Aug 17;22(1):209
pubmed: 30119699
Nucleic Acids Res. 2022 Jan 7;50(D1):D988-D995
pubmed: 34791404
Crit Care Med. 2018 Apr;46(4):570-576
pubmed: 29303798
J Clin Invest. 2001 Jan;107(1):45-52
pubmed: 11134179
Life Sci. 2003 May 23;73(1):93-102
pubmed: 12726890
Reprod Biomed Online. 2016 Aug;33(2):180-8
pubmed: 27210772
Sci Rep. 2021 May 13;11(1):10223
pubmed: 33986340
J Biol Chem. 1983 Mar 25;258(6):3803-8
pubmed: 6833231
IUBMB Life. 2013 Jun;65(6):550-63
pubmed: 23576524
FEBS J. 2007 Jan;274(2):377-89
pubmed: 17229145
Blood. 2011 Feb 17;117(7):2093-101
pubmed: 20971949
Biomolecules. 2017 Mar 02;7(1):
pubmed: 28257077
Nature. 2021 Oct;598(7882):634-640
pubmed: 34671162
Biochim Biophys Acta. 2007 Nov;1768(11):2667-80
pubmed: 17655823
Mol Immunol. 2009 Oct;46(16):3388-98
pubmed: 19674792
J Clin Invest. 1986 Apr;77(4):1305-11
pubmed: 3958188
PLoS Pathog. 2008 Aug 01;4(8):e1000116
pubmed: 18797515
Reprod Biomed Online. 2011 Aug;23(2):213-9
pubmed: 21665544
Blood. 2004 Dec 1;104(12):3631-4
pubmed: 15297315
Cancer Res. 2006 Feb 15;66(4):2089-97
pubmed: 16489009
Blood. 1998 Jan 1;91(1):128-33
pubmed: 9414276
Immunol Cell Biol. 2005 Apr;83(2):106-18
pubmed: 15748207
Thromb Res. 1996 Nov 1;84(3):179-88
pubmed: 8914217
Blood. 2015 Apr 23;125(17):2712-9
pubmed: 25691157
Int Rev Cell Mol Biol. 2013;304:467-93
pubmed: 23809442
Biochemistry. 1981 Mar 3;20(5):1054-61
pubmed: 7225317
Front Vet Sci. 2019 Mar 12;6:69
pubmed: 30931316
Biochem J. 2009 Oct 23;424(1):27-37
pubmed: 19712047
J Clin Invest. 1985 Jun;75(6):2065-73
pubmed: 4008652
EBioMedicine. 2016 Jul;9:180-194
pubmed: 27333033